Cleveland Diagnostics offers a novel class of simple blood tests that help identify presence or absence of disease. Our first product, IsoPSA, meets the chronic unmet need of a simpler, clearer way to rule out unnecessary prostate biopsies.
We envision the day when a cancer diagnosis is no longer feared. With our proprietary IsoClear platform leading the way, we’re giving physicians and their patients more definitive cancer insight earlier, allowing critical and even lifesaving decisions to be made sooner.
Cleveland Diagnostics was co-founded by the Cleveland Clinic, one of the world’s most highly regarded hospital systems. We’ve assembled an unparalleled team of scientific and medical experts from the diagnostic, pharmaceutical, and biotech industries as well as leading healthcare and academic institutions. Together we’re creating a new class of simple, affordable, and life- changing tests for cancer and other diseases.
